RBC Europe’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.83M | Sell |
5,648
-2,772
| -33% | -$899K | 0.09% | 84 |
|
|
2022
Q1 | $2.41M | Buy |
8,420
+400
| +5% | +$115K | 0.1% | 79 |
|
|
2021
Q4 | $2.22M | Sell |
8,020
-54,221
| -87% | -$15M | 0.1% | 78 |
|
|
2021
Q3 | $14.4M | Buy |
62,241
+58
| +0.1% | +$13.4K | 0.59% | 32 |
|
|
2021
Q2 | $14.3M | Buy |
62,183
+135
| +0.2% | +$31K | 0.65% | 31 |
|
|
2021
Q1 | $11.6M | Sell |
62,048
-60
| -0.1% | -$11.2K | 0.62% | 30 |
|
|
2020
Q4 | $10.5M | Hold |
62,108
| – | – | 0.6% | 30 |
|
|
2020
Q3 | $9.19M | Sell |
62,108
-1,810
| -3% | -$268K | 0.61% | 30 |
|
|
2020
Q2 | $10.5M | Sell |
63,918
-455
| -0.7% | -$74.7K | 0.81% | 21 |
|
|
2020
Q1 | $8.93M | Buy |
64,373
+52,321
| +434% | +$7.26M | 0.89% | 21 |
|
|
2019
Q4 | $1.58M | Hold |
12,052
| – | – | 0.14% | 93 |
|
|
2019
Q3 | $1.35M | Sell |
12,052
-220
| -2% | -$24.6K | 0.13% | 99 |
|
|
2019
Q2 | $1.36M | Sell |
12,272
-269
| -2% | -$29.8K | 0.14% | 100 |
|
|
2019
Q1 | $1.63M | Sell |
12,541
-642
| -5% | -$83.3K | 0.18% | 91 |
|
|
2018
Q4 | $1.53M | Buy |
13,183
+180
| +1% | +$20.8K | 0.2% | 85 |
|
|
2018
Q3 | $1.4M | Sell |
13,003
-570
| -4% | -$61.2K | 0.15% | 99 |
|
|
2018
Q2 | $1.16M | Hold |
13,573
| – | – | 0.14% | 104 |
|
|
2018
Q1 | $1.05M | Buy |
13,573
+303
| +2% | +$23.4K | 0.13% | 110 |
|
|
2017
Q4 | $1.12M | Sell |
13,270
-166
| -1% | -$14K | 0.14% | 104 |
|
|
2017
Q3 | $1.15M | Buy |
+13,436
| New | +$1.15M | 0.15% | 100 |
|